Popular Articles

Telemonitoring Systems At Heart Failure Congress 2009
Telemonitoring systems, by which the symptoms of heart failure can be remotely assessed, now provide a strategy for the improved personalised care of patients, according to Professor John Cleland from the University of Hull, UK.1 He told Heart Failure Congress 2009 that the management of heart failure is complex but most effective when tailored to the individual patients" needs and condition.2 "Unfortunately," he added, "the res required to offer this tailored treatment outside a hospital setting are generally not available. Current services provide, at best, only a crude attempt to deliver long-term, personalised healthcare, but telemonitoring provides a strategy which could radically change this situation."
generic viagra online
Home Smoking Rules Tend To Vary By Race
Prohibiting tobacco use at home could reduce adolescent smoking rates, but the practice might be less common in black families than in white ones, a new study found.
News of the day
Supreme Court Nominees Should Disclose Views On Constitutional Issues, USA Today Opinion Piece States
One thing that "has been conspicuously absent" from the confirmation hearings for Supreme Court nominee Sonia Sotomayor is "substance," Jonathan Turley, the Shapiro Professor of Public Interest Law at George Washington University, writes in a USA Today opinion piece. According to Turley, "The vast majority of questions and answers remained on a shallow and predictable level where Sotomayor did little more than describe current doctrines and case law -- avoiding disclosures of her own views." He continues, "What is most striking is how Sotomayor"s statements were virtually identical to both her conservative and liberal predecessors," including her comments that Roe v. Wade and Planned Parenthood v. Casey are "the precedent of the court."Turley writes, "The content-light character in these hearings is largely the product of the "Ginsburg rule" -- named after Justice Ruth Bader Ginsburg, who refused to answer questions in her 1993 confirmation hearing about any case or matter upon which she might later vote." According to Turley, "Later nominees for both parties have relied on the Ginsburg rule to turn the hearings into prolonged photo-ops for senators, who largely ask wafer-thin questions to solicit largely scripted answers." The rule "allows nominees to get by with meaningless sound bites that promise to respect precedent, the Framers [of the Constitution] and collegiality in general," he adds. Furthermore, it "tells the public nothing about a nominee"s philosophy or purpose before giving her life tenure on the world"s most powerful court," Turley writes.According to Turley, there is a "simple solution to returning substance to the confirmation process: End the Ginsburg rule by insisting that nominees answer questions about their specific views on constitutional rights." Although "the current system works well for presidents, nominees and senators," it "does little for the public or the system of justice," he writes (Turley, USA Today, 7/16).
Sexual Health

SYMBICORT(R) Added To Tiotropium Provided Clinically Significant Benefits For Patients With Severe COPD

Data presented at this year"s American Thoracic Society (ATS) congress, demonstrated that SYMBICORT® (budesonide/formoterol-TURBUHALER®, a dry powder inhaler) added to SpirivaTM (tiotropium) provided greater clinical improvements than tiotropium alone over a 12-week treatment period.1,2 Results of the CLIMB study showed that the occurrence of severe exacerbations was reduced by as much as 62 percent in patients where budesonide/formoterol was added to tiotropium (pReferences 1. Welte T, Miravitlles M, Peterson S et al. Budesonide/formoterol added to tiotropium improves the management of COPD patients. Abstract presented at American Thoracic Society (ATS) International Conference, San Diego, USA. May 15-20 2009 2. Welte T, Hartman L, Polanowski T et al. Budesonide/formoterol added to tiotropium is well tolerated and reduces risk of severe exacerbations in COPD patients. Abstract presented at American Thoracic Society (ATS) International Conference, San Diego, USA. May 15-20 2009 3. Partridge M, Karlsson N and Small I. Patient insights into the impact of COPD on morning symptoms, activities and daily life. Abstract presented at BTS 2008 4. Worth H, Peterson S, Nihlçİn U et al. Improved exercise tolerance with budesonide/formoterol vs placebo and formoterol in COPD patients. Abstract presented at American Thoracic Society (ATS) International Conference, San Diego, USA. May 15-20 2009 SYMBICORT, SYMBICORT SMART AND TURBUHALER are trademarks of the AstraZeneca group of companies -SYMBICORT is a combination of two proven medications - the inhaled corticosteroid (ICS), budesonide (Pulmicort®), and the fast-acting and long-acting bronchodilator (LABA), formoterol (Oxis®) in one inhaler - SYMBICORT is a rapid-acting combination therapy indicated for the long-term maintenance treatment of asthma, SYMBICORT SMART (Maintenance And Reliever Therapy), as well as Chronic Obstructive Pulmonary Disease (COPD), are all delivered via the SYMBICORT Turbuhaler device. SYMBICORT SMART and SYMBICORT Turbuhaler are not available in the U.S. AstraZeneca


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):